BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 13, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 21, 2019
View Archived Issues
Money raised by biotech: 2019 vs. 2018
Read More
Biopharma money raised: Jan. 1 - 17, 2019
Read More
Week in review
Read More
Week in Washington
Read More
Word on the street
Read More
Conference data: December 2018
Read More
Regulatory submissions, approvals and other actions: December 2018
Read More
Handing over the dealmaking torch, 2018 logs monster biopharma deals, paves the way for top M&As
Biopharma licensing deals signed in 2018 climbed to 1,364 and have a projected value of $119.54 billion, a four-year high for an industry still riding the immuno-oncology wave.
Read More
The week's biggest gainers and losers
Read More
BioWorld stock report for public biotechnology companies
Read More
